RECURSION PHARMACEUTICALS, INC. Quarterly Goodwill in USD from Q2 2020 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.
Summary
Recursion Pharmaceuticals, Inc. quarterly Goodwill history and growth rate from Q2 2020 to Q2 2024.
  • Recursion Pharmaceuticals, Inc. Goodwill for the quarter ending June 30, 2024 was $52.1M, a 14% decline year-over-year.
Goodwill, Quarterly (USD)
Goodwill, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q2 2024 $52.1M -$8.46M -14% Jun 30, 2024 10-Q 2024-08-08
Q1 2024 $52.1M +$51.3M +6399% Mar 31, 2024 10-Q 2024-05-09
Q4 2023 $52.1M +$51.3M +6399% Dec 31, 2023 10-Q 2024-08-08
Q3 2023 $52.8M +$51.9M +6486% Sep 30, 2023 10-Q 2023-11-09
Q2 2023 $60.5M +$59.7M +7455% Jun 30, 2023 10-Q 2023-08-08
Q1 2023 $801K $0 0% Mar 31, 2023 10-Q 2023-05-08
Q4 2022 $801K $0 0% Dec 31, 2022 10-K 2024-02-29
Q3 2022 $801K $0 0% Sep 30, 2022 10-Q 2022-11-08
Q2 2022 $801K $0 0% Jun 30, 2022 10-Q 2022-08-09
Q1 2022 $801K $0 0% Mar 31, 2022 10-Q 2022-05-10
Q4 2021 $801K $0 0% Dec 31, 2021 10-K 2023-02-27
Q3 2021 $801K Sep 30, 2021 10-Q 2021-11-10
Q2 2021 $801K +$801K Jun 30, 2021 10-Q 2021-08-13
Q1 2021 $801K Mar 31, 2021 10-Q 2021-05-12
Q4 2020 $801K Dec 31, 2020 10-K 2022-03-23
Q2 2020 $0 Jun 30, 2020 10-Q 2021-08-13
* An asterisk sign (*) next to the value indicates that the value is likely invalid.